Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04601103Terminated
Randomised, single-blind trial (3 arms), sponsored by Solventum. Primary endpoint: Number of Participants With Oral Mucosal Exfoliation (Oral Sloughing) at 3 weeks. Started Jan 2020; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04601103.